Home » Authors » Trista Morrison

Trista Morrison

Articles

ARTICLES

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

View All Articles by Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...